Real‐world practitioner perceptions of CARTITUDE‐4 results for patients with previously treated multiple myeloma
We have shown that making oncology practitioners aware of trials precipitated decision-making factors and led to notable, significant shifts in future intended practice patterns. Being aware of trial data enables practitioners to make more informed decisions, tailor therapies to individual patients, and ultimately improve outcomes.
Authors
- Alexandrina Balanean (ORCID: https://orcid.org/0000-0001-5540-0755)
- Muhamed Baljević (ORCID: https://orcid.org/0000-0002-0630-8458)
- Bruce A. Feinberg (ORCID: https://orcid.org/0000-0001-9267-9994)
- Brooke N. Dulka (ORCID: https://orcid.org/0000-0002-9930-4287)
- Samuel Baird
- Robert N. Bone (ORCID: https://orcid.org/0000-0003-3222-8918)
- Yolaine Jeune‐Smith (ORCID: https://orcid.org/0000-0002-1711-849X)
- Luke Jennings‐Zhang
Institutions
- Cardinal Health (United States) (US)
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- eJHaem
- Published
- 2024-11-25
- DOI
- https://doi.org/10.1002/jha2.1047
- Citations
- 1
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 0.28
Funders
- Cardinal Health